Microbot Medical Inc.

NasdaqCM MBOT

Microbot Medical Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending September 30, 2024

Microbot Medical Inc. EPS (Diluted) is NA for the Trailing 12 Months (TTM) ending September 30, 2024. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Microbot Medical Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -1.97, a -38.73% change year over year.
Microbot Medical Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -1.42, a -4.41% change year over year.
Microbot Medical Inc. EPS (Diluted) for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -1.36, a 24.44% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

NasdaqCM: MBOT

Microbot Medical Inc.

CEO	Mr. Harel Gadot
IPO Date	March 25, 1992
Location	United States
Headquarters	25 Recreation Park Drive
Employees	21
Sector	Technology
Industries Robotics 3D Printing Medical Instruments

Description

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Key trends

Past 5 years